Melanoma: open trials in South Korea

12 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT07519655
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Trial Treatment · Phase 1 · Pfizer
Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-11-05
NCT07492680
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Trial Treatment · Phase 2 · Bristol-Myers Squibb
Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul
Registry updated 2026-11-04
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Kyungpook National University Chilgok Hospital, Daegu · National Cancer Center, Gyeonggi-do · Seoul National University Bundang Hospital, Seongnam · CHA Bundang Medical Center, CHA University, Seongnam · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul
Registry updated 2026-10-26
NCT07115043
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · AstraZeneca
Seoul
Registry updated 2026-10-08
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Kyungpook National University Chilgok Hospital, Daegu · Seoul National University Hospital, Seoul
Registry updated 2026-10-06
NCT05727904
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Trial Treatment · Phase 3 · Iovance Biotherapeutics, Inc.
Bundang Medical Center - CHA University, Seongnam-si · Korea University Anam Hospital, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-09-24
NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Trial Treatment · Phase 1/2 · Inhibrx Biosciences, Inc
The Catholic University of Korea St. Vincent's Hospital, Gyeonggi-do · Asan Medical Center, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-07-29
NCT02332668
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
MSD Korea LTD, Seoul
Registry updated 2026-07-06
NCT07449754
Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
Trial Treatment · Phase 2 · Hanmi Pharmaceutical Company Limited
Dong-A University Medical Center, Busan · Kyungpook National University Chilgok Hospital, Daegu · Chungnam National University Hospital, Daejeon · Chonnam National University Hwasun Hospital, Hwasun · Seoul National University Bundang Hospital, Seongnam-si · Korea University Guro Hospital, Seoul · Severance hospital, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul
Registry updated 2026-03-04
NCT05877430
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
Trial Treatment · Phase 1/2 · CJ Bioscience, Inc.
Severance hospital, Seoul · Samsung Medical Center, Seoul
Registry updated 2024-12-20
NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Trial Treatment · Phase 1/2 · GI Innovation, Inc.
Seoul National University Hospital, Seoul · Yonsei University Health System, Severance Hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul · St. Vincent's Hospital, Suwon
Registry updated 2024-11-25
NCT06265025
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · GeneMedicine Co., Ltd.
National Cancer Center, Goyang-si · Korea University Anam Hospital, Seoul · Hanyang University Seoul Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2024-03-21

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error